BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Treatment
30 results:

  • 1. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
    Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
    BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intratumoral dendritic cell-CD4
    Magen A; Hamon P; Fiaschi N; Soong BY; Park MD; Mattiuz R; Humblin E; Troncoso L; D'souza D; Dawson T; Kim J; Hamel S; Buckup M; Chang C; Tabachnikova A; Schwartz H; Malissen N; Lavin Y; Soares-Schanoski A; Giotti B; Hegde S; Ioannou G; Gonzalez-Kozlova E; Hennequin C; Le Berichel J; Zhao Z; Ward SC; Fiel I; Kou B; Dobosz M; Li L; Adler C; Ni M; Wei Y; Wang W; Atwal GS; Kundu K; Cygan KJ; Tsankov AM; Rahman A; Price C; Fernandez N; He J; Gupta NT; Kim-Schulze S; Gnjatic S; Kenigsberg E; Deering RP; Schwartz M; Marron TU; Thurston G; Kamphorst AO; Merad M
    Nat Med; 2023 Jun; 29(6):1389-1399. PubMed ID: 37322116
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Zymolytic grain extract facilitates the conversion of liver tumor cells to hepatocyte-like cells through hepatocyte nuclear factors.
    Hao C; Guo X; Dong Z; Guo Q; Shi W
    Biomed Pharmacother; 2023 Jan; 157():114029. PubMed ID: 36436492
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. In vitro and Pharmacoinformatics-based phytochemical screening for anticancer impacts of pistachio hull essential oil on AGS, PLC/PRF/5, and CACO2 cell lines.
    Askari N; Parvizpour S; Marashi SMB; Baghery F; Khanamani Falahati-Pour S
    Mol Biol Rep; 2023 Jan; 50(1):465-473. PubMed ID: 36348196
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Benign liver tumours: understanding molecular physiology to adapt clinical management.
    Nault JC; Paradis V; Ronot M; Zucman-Rossi J
    Nat Rev Gastroenterol Hepatol; 2022 Nov; 19(11):703-716. PubMed ID: 35835851
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma.
    Katabathina VS; Khanna L; Surabhi VR; Minervini M; Shanbhogue K; Dasyam AK; Prasad SR
    Radiographics; 2022; 42(5):1338-1357. PubMed ID: 35776676
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Direct Conversion of Human Endothelial Cells Into liver cancer-Forming Cells Using Nonintegrative Episomal Vectors.
    Goya T; Horisawa K; Udono M; Ohkawa Y; Ogawa Y; Sekiya S; Suzuki A
    Hepatol Commun; 2022 Jul; 6(7):1725-1740. PubMed ID: 35220676
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EPHB2 Activates β-Catenin to Enhance cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Young JR; Graham RP; Venkatesh SK; Kendi AT
    Abdom Radiol (NY); 2021 Jun; 46(6):2604-2609. PubMed ID: 33555390
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
    Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
    Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary hepatocellular adenoma due to biallelic hnf1a mutations and its co-occurrence with MODY 3: case-report and review of the literature.
    Fu J; Wang T; Zhai X; Xiao X
    Endocrine; 2020 Mar; 67(3):544-551. PubMed ID: 31754975
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.
    Alunni-Fabbroni M; Rönsch K; Huber T; Cyran CC; Seidensticker M; Mayerle J; Pech M; Basu B; Verslype C; Benckert J; Malfertheiner P; Ricke J
    J Transl Med; 2019 Oct; 17(1):328. PubMed ID: 31570105
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnosis of hepatocellular adenoma in men before onset of diabetes in hnf1a-MODY: Watch out for winkers.
    Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
    Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Acetaminophen-induced hepatocyte injury: C2-ceramide and oltipraz intervention, hepatocyte nuclear factor 1 and glutathione S-transferase A1 changes.
    Chang Y; Wang F; Yang Y; Zhang Y; Muhammad I; Li R; Li C; Li Y; Shi C; Ma X; Hao B; Liu F
    J Appl Toxicol; 2019 Dec; 39(12):1640-1650. PubMed ID: 31385618
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
    Howell J; Atkinson SR; Pinato DJ; Knapp S; Ward C; Minisini R; Burlone ME; Leutner M; Pirisi M; Büttner R; Khan SA; Thursz M; Odenthal M; Sharma R
    Eur J Cancer; 2019 Jul; 116():56-66. PubMed ID: 31173963
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The hnf1α-regulated lncRNA hnf1a-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
    Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
    Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction.
    van Breda SGJ; Claessen SMH; van Herwijnen M; Theunissen DHJ; Jennen DGJ; de Kok TMCM; Kleinjans JCS
    Toxicology; 2018 Jan; 393():160-170. PubMed ID: 29154799
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PET-avid hepatocellular adenomas: incidental findings associated with hnf1-α mutated lesions.
    Lee SY; Kingham TP; LaGratta MD; Jessurun J; Cherqui D; Jarnagin WR; Kluger MD
    HPB (Oxford); 2016 Jan; 18(1):41-8. PubMed ID: 26776850
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Gene mutations in hepatocellular adenomas.
    Raft MB; Jørgensen EN; Vainer B
    Histopathology; 2015 Jun; 66(7):910-21. PubMed ID: 25195525
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.